Advertisement

Dobutamine Injection

[08 September 2014]

Products Affected - Description

Dobutamine injection, West-Ward (formerly Bedford product)
12.5 mg/mL, 20 mL vial (NDC 55390-0560-90)
 
Dobutamine injection, Hospira
500 mg/250 mL premix (NDC 00409-2347-32)

Reason for the Shortage

  • Baxter had dobutamine on back order due to increased demand and manufacturing constraints.
  • Hospira has dobutamine on shortage due to manufacturing delays.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired several products from Bedford Laboratories in July 2014 including dobutamine injection.

Available Products

Dobutamine injection, Baxter
250 mg/250 mL premix (NDC 00338-1073-02)
500 mg/250 mL premix (NDC 00338-1075-02)
1000 mg/250 mL premix (NDC 00338-1077-02)
 
Dobutamine injection, Hospira
12.5 mg/mL, 20 mL latex-free vial (NDC 00409-2025-20)
12.5 mg/mL, 40 mL latex-free vial (NDC 00409-2025-54)
12.5 mg/mL, 20 mL vial, 1 count (NDC 00409-2344-01)
12.5 mg/mL, 20 mL vial, 10 count (NDC 00409-2344-02)
250 mg/250 mL premix (NDC 00409-2346-32)
1000 mg/250 mL premix (NDC 00409-3724-32)

Estimated Resupply Dates

  • West-Ward has dobutamine 12.5 mg/mL 20 mL vials on back order and the company cannot estimate a release date.
  • Hospira has dobutamine 500 mg/250 mL premixes on back order and the company estimates a release date in September 2014.

Related Shortages

Updated

September 8, 2014; August 29, 2014; August 1. 2014; July 11, 2014; June 19, 2014; May 19, 2014; April 1, 2014; March 14, 2014; March 13, 2014; March 7, 2014; February 5, 2014; January 29, 2014; January 21, 2014; December 30, 2014; December 18, 2013; November 14, 2013; October 9, 2013; September 30, 2013; September 18, 2013; September 13, 2013; August 14, 2013; August 1, 2013; July 3, 2013; June 28, 2013; June 26, 2013; June 13, 2013; May 14, 2013; May 6, 2013; April 24, 2013; March 26, 2013; March 1, 2013; February 6, 2013; January 23, 2013; January 4, 2013; December 10, 2012; November 28, 2012; October 17, 2012; September 27, 2012; August 2, 2012; July 25, 2012; July 3, 2012; June 27, 2012; June 22, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement